Announcements Trials
Browse Landscape

Status

Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 4

Study Type

Observational 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Breast Neoplasms 2936Neoplasms 2634Lung Neoplasms 1371Colorectal Neoplasms 1332Prostatic Neoplasms 1216Carcinoma, Non-Small-Cell Lung 1080Carcinoma, Hepatocellular 784Stomach Neoplasms 721Pancreatic Neoplasms 704Ovarian Neoplasms 586Colonic Neoplasms 534Uterine Cervical Neoplasms 497Head and Neck Neoplasms 496Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 423Neoplasm Metastasis 418Brain Neoplasms 405Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Urinary Bladder Neoplasms 387Leukemia, Myeloid, Acute 387Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 313Recurrence 298Disease 275

Interventions

darolutamide 4enzalutamide 2apalutamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Non-metastatic Castration-resistant Prostate Cancer × Clear all
NCT07538843 2026-05-15

DARE

Bayer

Not yet recruiting
800 enrolled
Genitourinary

Non-metastatic Castration-resistant Prostate Cancer

NCT06334120 2026-05-13

An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

Bayer

Recruiting
600 enrolled
Genitourinary

Non-metastatic Castration-resistant Prostate Cancer

NCT06013475 2025-06-12

DEAR-EXT

Bayer

Completed
1,375 enrolled
Genitourinary

Non-metastatic Castration-resistant Prostate Cancer

NCT05362149 2024-03-20

DEAR

Bayer

Completed
870 enrolled
Genitourinary

Non-metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡